National Therapeutic Indicators – How can EMIS help? Dr Keith Burns, EMIS NUG Committee, Broadbay Medical Practice, Stornoway.

Slides:

Advertisements

Similar presentations

Update on Clinical Surveillance

Advertisements

Pathways – Dr Duncan Fowler

KAVITHA KANAKANTI.  To confirm the number of patients who were on Clopidogrel are taking Proton Pump Inhibitors.

Norman Evans Chief Pharmacist Wandsworth PCT South West London Finding The Resources – The Cost Challenge.

PCGs and Prescribing Audit Presentation at EMIS National User Group Conference Nottingham September 17 th 1999 DR Amrit Takhar GP, Wansford, Peterborough.

European drug statistics What is the reason for the differences between the various EU countries Ulrich Schwabe Pharmakologisches Institut der Ruprecht-Karls-Universität.

ANTIMICROBIAL PLAN STICKER Improving Antimicrobial documentation with the use of an Antimicrobial Plan sticker Evonne Fong, Pharmacy Department AHS, ICU.

Antibiotic Stewardship & Electronic Prescribing On behalf of the EP team Dr Chris Green Director of Pharmacy October 2014.

Taking EMIS to extremes SCIMP 2013 Dr Duncan Lamont.

Royal Free Hampstead NHS Trust Pharmacist Intervention in Electronic Discharge Prescribing in Acutely Ill Patients Anna Yortt John Farrell, Sally Dootson.

DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.

NHS Formularies Fiona Graham Formulary Pharmacist NHS Lanarkshire.

NHS Lanarkshire Joint Formulary Fiona Graham Formulary Pharmacist.

National Prescribing Indicators 2015 – National Prescribing Indicators (NPIs) development process Developed by the All Wales Prescribing Advisory.

Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009.

2007 Medical Education Conference Conférence de 2007 sur l’éducation médicale Welcome AFMC – CAME – CFPC – MCC – RCPSC AFMC – ACÉM – CMFC – CMC – CRMCC.

Virginia Medicaid Preferred Drug List and Other Pharmacy Programs: What You Need To Know Presented by: Department of Medical Assistance Services and First.

Poster template by ResearchPosters.co.za Independent Pharmacist Prescriber Led Polypharmacy Clinics Pilot in Windsor, Ascot and Maidenhead CCG Melody Chapman,

Ministry of Health People’s Republic of ChinaPage 1 中华人民共和国卫生部 Promoting Rational Antibiotic Prophylaxis in Clean Surgeries in China, Zheng, Yingdong;

Prior Authorization Criteria for PDL Classes: Alzheimer’s Anti-emetics High Potency Statins Hormone Replacement Therapy Multiple Sclerosis – Tysabri Charles.

NHS Formularies Fiona Graham Formulary/Clinical Effectiveness Pharmacist NHS Lanarkshire.

London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.

The 30 Minute BPMH Work Out: Tips, Tools and Strategies for Getting an Efficient and Complete Best Possible Medication History Olavo Fernandes BScPhm,

A Team Approach at MRMC Kimberly E. Knox, RN, MHA, CIC.

What’s the point of Ezetimibe? MeReC dio/cdlipids/merec_extra_no47.html.

The 5x5 Antimicrobial Audit is a component of the QUAH Antimicrobial Stewardship Toolkit Based on Prescribing Indicators developed by the Scottish Antimicrobial.

Department of Public Health and Preventive Medicine Drug Effectiveness Review Project: States Working Together to Find Best Available Evidence The National.

DRUG TEXT. DRUG TEXT ENTRY  Can copy from Excel, WORD, or Text files  Use SCREEN EDITOR to edit data  PDM > DRUG TEXT ENTER/EDIT.

Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July June 2008 ) © Copyright NHSBSA 2008.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

Deprescribing with Emphasis on Anticholinergic Burden Dr. Lesley Hannah, Portlethen Medical Centre 2014 I am responsible for providing medical care to.

Achievement of cholesterol targets and prescribing of higher-cost statins: a cross-sectional study in general practice by Robert Fleetcroft, Peter Schofield,

Online additional material Appendix Table 1: Medications Groups Appendix Table 2: Doctors' orders in hemodialysis units Additional Figure 1: Beta Blockers.

AHCCCS Pharmacy and Therapeutics Committee October 20, Reaching across Arizona to provide comprehensive quality health care for those in need.

FINANCIAL IMPACT OF JUDICIOUS USE OF MEDICINE IN PRIMARY CARE Zuo, Yeqin; Morrell, Stephen; Dartnell, Jonathan; Wu Fred; Weekes, Lynn NPS: Better Choices,

Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,

In the Best Interests of the Public Health... Janice Soreth, M.D. Acting Director Division of Anti-Infective Drug Products CDER/FDA.

Responsible Respiratory Prescribing

Questions to Committee about Potential Cancer Risk with Use of Topical Immunosuppressants (Calcineurin Inhibitors) Question 1: Messages about Risk A. Based.

How the Clinical Effectiveness Team can help you to audit your Prescribing Practice Jude Scott Clinical Governance & Risk Management Unit Clinical Effectiveness.

Jane Stockley Chris Catchpole Carole Clive November 2012.

Prescribing in cardiovascular disease By Jole Hannan Medicines Optimisation Pharmacist.

Local Marketing | Promotion | Training By Mina Georgy.

The Linneaus implementation in Greece Yannis Skalkidis MD, PhD, MPH, FACS Athens University Medical School ΕΘΝΙΚΟ & ΚΑΠΟΔΙΣΤΡΙΑΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ NATIONAL.

PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.

Bridging the Gap collaborating to spread improvement National Medicines Management Programme & All Wales Chief Pharmacists Sept 7 th 2012 All Nations Centre,

An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.

Double-blind, randomized trial in 4,162 patients with Acute Coronary Syndrome

JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.

EPrescribing at University Hospitals Birmingham NHS Foundation Trust Ann Slee Director of Pharmacy

Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong

Audit Opioid use in palliative patients on general hospital wards

Daniel Phillips Antimicrobial Pharmacist

Adverse events for rosuvastatin

Muscle pain with taking statin

Fig. 1. Example of proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia in a patient pre-dating the original description in The patient,

Newbury and District CCG MOT Update - May 2015

Prescriber Led Antibiotic Audits and Ward Rounds

C.Difficile update – what you need to know in Primary Care

Basic principles of DDIs with ARVs: an introduction

COMPUS Overview Denis Bélanger Heather Bennett Steve Graham

Health Information Systems: Functional Capacity

Lipid Updates From Spring 2019

Updates on Dyslipidemia

Priscilla A. Zetstra–van der Woude, MSc, J. Sebastiaan Vroegop, MD, H

Strategies to Improve Drug Use

Presentation transcript:

National Therapeutic Indicators – How can EMIS help? Dr Keith Burns, EMIS NUG Committee, Broadbay Medical Practice, Stornoway

National therapeutic indicators

THE NATIONAL THERAPEUTIC INDICATORS 2012 (in order of BNF chapter): Proton Pump Inhibitors: DDDs per 1,000 patients per day. Proton Pump Inhibitors: high strength PPIs as a % of all PPIs (DDDs) Statins: Simvastatin, atorvastatin & pravastatin as a percentage of all statins (DDD) Ezetimibe: Ezetimibe as a percentage of ezetimibe and all statins (DDDs) Dipyridamole MR: Dipyridamole DDD per 1,000 patients per day High Strength Inhaled Corticosteroids: High Strength Inhaled Corticosteroids as a percentage of all inhalers (items) Hypnotics: Hypnotics and anxiolytics DDD per patients per day Total Antibiotic Use: total items per 1,000 patients per day 4C Antibiotics: proportion of ‘4C antibiotics’ (fluoroquinolones,cephalosporins, co-amoxiclav and climamycin) items per 1,000 patients per day Quinine Use: DDDs per 1000 patients per day Antidiabetic drugs: established oral hypoglycaemics (metformin & sulphonylureas) as percentage of all antidiabetic drugs (DDDs) Antimicrobial Wound Products: Antimicrobial wound products as percentage of total wound products (items)

Main strategies Removal or replacement as a batch Prompting for clinicians Targeting in clinics Use of Scriptswitch were available

Some just education only Total antibiotic use – remove from repeats or review long term use for UTIs? Antidiabetic drugs Antimicrobial wound products – possible use of warnings if nurses prescribe using EMIS

Removal or replacement Ezetemibe Dipyridamole MR High strength PPI Hypnotics? – difficult Do a search, batch print letters and then work through the EMIS numbers

Prompting for clinicians PPI Statins All of the previous ones in order to stop re- starting 4C antibiotics Use of warning messaging in EMIS

Targeting in clinics / med reviews PPI High strength inhaled corticosteroids Quinine Prompts on templates and regular reminders for clinicians to review.

Use of Scriptswitch Helping with the replacement of drugs – Dipyridamole MR Warning for all indicators